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Abstract
Background: Mycobacterial infections remain a significant cause of morbidity and mortality worldwide. Due to
limitations of the currently available model systems, there are still comparably large gaps in the knowledge about
the pathogenesis of these chronic inflammatory diseases in particular with regard to the human host. Therefore,
we aimed to characterize the initial phase of mycobacterial infections utilizing a human ex vivo lung tissue culture
model designated STST (Short-Term Stimulation of Tissues).
Methods: Human lung tissues from 65 donors with a size of 0.5–1 cm3 were infected each with two strains of
three different mycobacterial species (M. tuberculosis, M. avium, and M. abscessus), respectively. In order to preserve
both morphology and nucleic acids, the HOPE® fixation technique was used. The infected tissues were analyzed
using histo- and molecular-pathological methods. Immunohistochemistry was applied to identify the infected cell
types.
Results: Morphologic comparisons between ex vivo incubated and non-incubated lung specimens revealed no
noticeable differences. Viability of ex vivo stimulated tissues demonstrated by TUNEL-assay was acceptable. Serial
sections verified sufficient diffusion of the infectious agents deep into the tissues. Infection was confirmed by Ziel
Neelsen-staining and PCR to detect mycobacterial DNA. We observed the infection of different cell types, including
macrophages, neutrophils, monocytes, and pneumocytes-II, which were critically dependent on the mycobacterial
species used. Furthermore, different forms of nuclear alterations (karyopyknosis, karyorrhexis, karyolysis) resulting in
cell death were detected in the infected cells, again with characteristic species-dependent differences.
Conclusion: We show the application of a human ex vivo tissue culture model for mycobacterial infections. The
immediate primary infection of a set of different cell types and the characteristic morphologic changes observed in
these infected human tissues significantly adds to the current understanding of the initial phase of human pulmonary
tuberculosis. Further studies are ongoing to elucidate the molecular mechanisms involved in the early onset of
mycobacterial infections in the human lung.
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Background
Mycobacterial infections are still a major cause of
morbidity and mortality worldwide. In 2013 (WHO)
an estimated number of 9.0 million people developed
Tuberculosis (TB) and 1.5 million people died of this
chronic inflammatory disease [1]. It is currently not
clear whether the comprehensive strategies developed
by the WHO will lead to the elimination of this in-
fectious disease by 2050. Independently, nontubercu-
lous mycobacterial (NTM) infections mainly caused
by M. avium, M. intracellulare, M. abscessus, and M.
chelonae are increasing [2]. NTM are ubiquitous in
the environment and can cause a wide range of infec-
tions in humans, as well as in animals [3]. Many
different animal models have been developed in
mycobacterial research since Robert Koch’s period.
However, existing models have so far failed to mimic
human disease. Major disadvantages include signifi-
cant differences in mycobacteria-induced pathology
and relative resistance (mice and rats), high costs
(non-human primates), or different immunological
capacities compared to humans (guinea pigs and rab-
bits) [4–8]. Thus the lack of appropriate models for
basic research in mycobacterial infection of the hu-
man host hampers new insights into disease mecha-
nisms and scientific progress with regard to successful
measures to accomplish that goal [9].
Various in vitro models with human cells have been
established. However the results obtained by different
research groups are often hard to compare [10] due to
the use of different bacterial strains and infection doses
[11, 12] and the large differences in study design includ-
ing different (i) cell types (monocytes, macrophages,
neutrophils, and microglia [13–16]), (ii) cell lines (macro-
phage-like cells and non-phagocytic cell lines [17–21]), (iii)
host cell sources (human, healthy or patients, and animals
[22–24]), and (iv) last but not least incubation media (con-
taining supplements or not [25, 26]). In addition, most of
the gathered information indicates that it is extremely diffi-
cult to induce mycobactericidal activity in purified popula-
tions of phagocytes. Therefore, some more complex
models have been developed, e. g. co-culture of immune
cells [13], whole blood assays [27], or microenvironments
comprising epithelial and endothelial cells [28], as well as
the use of distinct stimuli (e.g. cytokines, vitamins, lipids,
and nucleotides [29–32]). Nonetheless, these large varia-
tions of results do not allow definite conclusions.
From a host perspective it needs to be mentioned that
50 % of individuals exposed to M. tuberculosis (Mtb)
never become tuberculin skin test positive, which may
indicate that the mycobacterium is removed by the in-
nate immunity [33]. Likewise, there are several lines of
epidemiological evidence supporting a protective role for
innate immunity in tuberculosis. The successful elimination
of pathogenic mycobacteria early on during infection by the
innate immune-system is still controversially discussed and
very likely underestimated due to the lack of human
studies.
In order to study early innate effector mechanisms
upon mycobacterial infection and on the current lack
of complex human-relevant models, an ex vivo tissue
culture model, referred as STST (Short-Term Stimula-
tion of Tissues), was developed. The main advantage
of this lung tissue model is the maintenance of the
intact lung microenvironment with its native cell
population, orientation, and structural integrity. The
STST model of human lung tissue has been success-
fully used to obtain valuable information about early
steps in the pathogenesis of several infectious lung
diseases, including infections with Legionella pneumophila,
Pseudomonas aeruginosa, Streptococcus pneumonia, Chla-
mydia pneumoniae, and Haemophilus influenzae [34–38].
Methods
Ethical statement and collection of samples
Human lung tissue specimens were acquired from surgi-
cal material of 65 patients, who underwent pneumonec-
tomy or lobectomy due to cancer at the LungenClinic
Grosshansdorf, Germany. The study was performed with
permission of the local ethical committee at the University
of Lübeck, written informed consent was obtained
(Approval number: 07–157).
Bacterial strains and culture
Following strains were used for the study at different col-
ony forming units (CFU)/ml (104–107), which were culti-
vated in Löwenstein–Jensen medium (LJ): M. abscessus
9547/00 (type strain, =AB1), M. abscessus 8562/11 (clin-
ical isolate, =AB2), M. avium 3725/07 (strain 104, =AV2),
M. avium 3439/10 (clinical isolate, =AV1), M. tuberculosis
9679/00 (type strain H37Rv, =TB2), and M. tuberculosis
1616/12 (clinical isolate from a German patient, =TB1). In
order to precipitate mycobacterial clumps, suspensions
were centrifuged at low speed (100 × g) for 5 min. BBL™
MGIT™ PANTA™ antibiotic mixture (BD diagnostics,
USA) was added to the suspensions to prevent other bac-
terial growths. The concentrations of viable mycobacteria
(CFU/ml) in the stock suspensions were controlled three
times during the study. Basically, the stock solutions were
serially diluted (1:10 each) until 100 CFU/ml. From 100 to
103 CFU/ml 0.3 ml were cultured in petri dishes contain-
ing LJ medium. Cultivation time for M. abscessus was 1–2
weeks and for M. avium, as well as M. tuberculosis 4–6
weeks, respectively. The mycobacterial colonies were
counted visually and the CFU/ml were determined. For
infection of the lung tissue specimens, 2 ml of suspension
from each strain were used.
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Infection of the lung tissue specimens
Under gross morphologic examination, only parts of the
surgical materials without inflammatory consolidations,
pleura, neoplasia, or anthracosis, were selected and dis-
sected with a size of 0.5–1 cm3 (~30 mg) for the investi-
gation. In order to optimize the viability of the tissues in
the ex vivo system, as well as to determine the best suit-
able amount of tissues and volume of culture medium,
MTT assays [(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-
razolium bromide] have initially been performed (data
not shown). According to these, each piece of tissue was
infected with 2 ml of the suspensions. To distribute the
mycobacteria, medium was gently re-suspended by pip-
etting. Infection and cultivation of tissues were per-
formed for 16 h in RPMI1640 (1×) GlutaMAX™-I
(Invitrogen, Darmstadt, Germany) supplemented with
10 % FCS (PPA, Pasching, Austria), 0.02 M HEPES buf-
fer solution (Life technologies, Invitrogen, Carlsbad,
California, USA), and 0.01 mM sodium pyruvate (Bio-
chrom, Berlin, Germany) at 37 °C overnight in 24-well,
flat bottom Corning® Costar ® tissue culture plates
(Sigma-Aldrich Co., St. Louis, USA). Titration experiments
were initially carried out to select optimal infection dose of
mycobacteria, where the highest number of infected cells
was obtained. Thus a CFU/ml of 107 was used for all ex-
periments. Additionally, two kinds of control tissues were
included, one was freshly fixed without cultivation, and an-
other was incubated under the same culture conditions
without mycobacterial infection (medium control).
Tissue processing and histopathological analysis
HOPE® fixation technique (HEPES-glutamic acid buffer
mediated Organic solvent Protection Effect) (DCS Diag-
nostics, Hamburg, Germany) was used as previously pub-
lished [39, 40]. There were no washing steps for the ex
vivo infected tissues before fixation. Briefly, specimens
were fixed in HOPE® solution at 4 °C overnight. Dehydra-
tion procedure was performed with 100 % acetone at 4 °C
and repeated 4 times. Tissue samples were directly em-
bedded in low-melting paraffin (DCS labLine, Germany).
Tissue blocks were cut on a microtome, sections were
deparaffinized with isopropanol (2×10 min at 60 °C) and
subsequently visualized by histological stainings depend-
ing on purposes: 1) Hematoxylin and Eosin (H&E) stain-
ing, allowing a general morphological inspection after ex
vivo incubation (Merck, Darmstadt, Germany), 2) Gram
staining for the detection of gram-positive bacterial con-
tamination (Merck, Darmstadt, Germany), 3) cold Ziel
Neelsen (ZN) technique/Kinyoun staining for the detec-
tion of mycobacteria (bioMérieux SA, Craponne, France).
IHC and fluorescence double staining
Double-staining was performed comprising IHC (to iden-
tify cell types) with Auramine-Rhodamine fluorescence
staining (to detect mycobacteria) (Waldeck GmbH & Co.
KG, Münster, Germany). For immunohistochemical
staining, following antibodies were used depending on
the purpose. Herein: Anti-Human CD 68 for macro-
phages (diluted 1:200, clone: PG-M1, monoclonal,
mouse, Dako Cytomation, Glostrup, Denmark), Anti-
Human Neutrophil Elastase (NE) for neutrophils (diluted
1:200, clone: NP57, monoclonal, mouse, Dako Cytomation,
Glostrup, Denmark), Anti-Surfactant Protein-C (SP-C) for
pneumocytes-II (diluted 1:300, clone: FL-197, polyclonal,
rabbit, Santa Cruz Biotechnology Inc., Dallas, Texas,
U.S.A.), for lymphoid cells Anti-Human T cell, CD8
(diluted 1:50, clone: C8/144B, monoclonal, mouse, Dako
Cytomation, Glostrup, Denmark), Anti-Human CD20cy, B
cell (diluted 1:100, clone: L26, monoclonal, mouse, Dako
Cytomation, Glostrup, Denmark), Anti-human CD30,
(diluted 1:50, clone: Ber-H2, monoclonal, mouse, Dako
Cytomation, Glostrup, Denmark), Anti-Human T cell, CD4
(diluted 1:100, clone: MT310, monoclonal, mouse, Dako
Cytomation, Glostrup, Denmark), and Anti-Human CD79a
(diluted 1:200, clone: SP18, monoclonal, rabbit, DCS
Innovative Diagnostik-System GmbH & Co, Hamburg,
Germany). For detection, the ZytoChemPlus (HRP) Poly-
mer kit (Zytomed Systems, Berlin, Germany) was applied
with above mentioned antibodies and Diaminobenzidine
(DAB) as substrate. After IHC staining, the slides were
subsequently transferred to Auramine-Rhodamine dye
(15 min), HCl- Alcohol 70 % (2 min) and potassium
permanganate (KMnO4) 0.5 % (2 min 30 s) in the dark.
Examination and capture of images were carried out by
a fluorescence microscope (Eclipse 80i, Nikon). In
order to provide simultaneous detection of double
staining, the same area of fluorescent photomicrographs
of the fluorochrome (Rhodamine/TRITC, spectral charac-
teristics: 550–580) and color inverted brightfield-images
of the IHC detection were overlaid (FixFoto).
Measurements of cellular components
The following parameters were measured: 1) Cytoplas-
mic and nuclear diameters, 2) Light densities (LDs) of
cytoplasm and nucleus. Then, N/C ratio (a ratio of the
nuclear size to the cytoplasmic size) and arithmetic
mean of nuclear and cytoplasmic LDs were estimated.
All measurements were performed with the Infinity
analyze software after background correction. To keep
measuring light densities of cells constant camera con-
trol options were kept at a magnification of 400×, expos-
ure time = 200 ms, gain = 2, gamma = 1, color correction
matrix/light source = daylight.
Viability test
TUNEL (Terminal deoxynucleotidyl transferase dUTP
nick end labeling) assay was performed in HOPE-
preserved tissue sections. The slides were initially
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incubated for 15–30 min at 37 °C with proteinase K and
rinsed twice with PBS buffer. After adding TUNEL reac-
tion mixtures, the slides were incubated at 37 °C in hu-
midified atmosphere for 1 h and again rinsed 3 times
with PBS buffer. All procedures were carried out in a
dark environment. Freshly HOPE-fixed lung tissues
served as positive control (alive), whereas tissues
treated by DNase I served as negative control. For
counter staining Vectashield mounting medium with
4′–6-diamidino-2-phenylindole (DAPI) was used
(Vector Laboratories, Burlingame, USA). Examination
and capture of images were performed by a fluores-
cence microscope (Eclipse 80i, Nikon). Cell counts
were acquired using Infinity Analyze software after
adjustment of linear contrast. With a purpose of ana-
lyzing viability, integrated measurements of all ex vivo
incubated samples were compared with positive (un-
treated lung specimens) and negative controls (DNase
I treated lung specimen).
Software and statistics
FixFoto (version 3.20, Joachim Koopmann Software,
Wrestedt/Stederdorf, Germany), Image J (version 1.48b,
Wayne Rasband, Maryland, USA), Infinity analyze (ver-
sion 6.0.02, Lumenera corporation, Ontario, Canada)
were used for optimizing micrographs. IBM SPSS (ver-
sion 20.0.0, IBM Corporation, New York, United States)
and Graph Pad Prism 6 (version 6.04, GraphPad
Software, Inc. California, USA) were used for statistical
analysis. Statistical tests were chosen as indicated in the
figure legends. A p-value <0.05 was considered statistically
significant. Correspondence analysis was performed using
MATLAB (MathWorks, Inc., Natick, MA, USA) as de-
scribed [41].
Results
The STST model in the analysis of mycobacterial
infections
The morphology of all incubated tissues (in the absence
or presence of mycobacteria) was explored and com-
pared to non-incubated, freshly fixed lung tissues by
H&E staining. No noticeable differences were detected
among the collected specimens at tissue level. The via-
bility of tissues after incubation was evaluated by
TUNEL assay, which detects DNA double-strand breaks
during apoptosis, allowing the quantification of myco-
bacteria dependent cell death (Fig. 1 and Table 1).
Altogether, 96.64 ± 3.65 % of cells in the positive con-
trols (fresh lung preparations without ex vivo cultiva-
tion) were viable compared to 62.09 ± 11.95 % in the
negative controls (treated by DNase I). The ex vivo
STST samples revealed 92.85 ± 6.99 % of living cells in
total, while 7.15 ± 6.99 % were apoptotic as demonstrated
by positive staining for TRITC.
In order to detect mycobacterial infections and also
other possible bacterial contaminations, all samples were
stained by Ziehl Neelsen (ZN) and Gram-staining in
parallel. Consequently, all cases of ex vivo infected
STST-samples were ZN-positive while Gram-stainings
remained negative. For verification of mycobacterial in-
fection in the human ex vivo tissues, specimens were
screened for the detection of mycobacterial DNA by
PCR (Polymerase chain reaction). Mycobacterial DNA
was not detected in medium controls (negative), whereas
samples from the infected tissues were positive with
regards to the mycobacterial species used for infection
(data not shown). Confirmation of infecting strains was
performed by DNA-sequencing of the PCR-products.
Since mycobacteria are non-motile, we measured how
deep the bacilli infiltrate in a given tissue. To this end, ser-
ial sections of one whole tissue block were prepared and
analyzed by ZN-staining (Fig. 2a). Statistical analysis by
Mann–Whitney U-test revealed the mean rank of infected
Fig. 1 Results of the TUNEL assays. PC = Positive Control (fresh
lung preparations without ex vivo cultivation, N = 17), ev: Mean
of all different ex vivo cultivated lung specimens, including Medium
control (MED, N = 12), lungs infected with M. abscessus (AB, N = 17),
M. avium (AV, N = 7) and M. tuberculosis (TB, N = 18). NC = Negative
Controls (treated by DNase I, N = 8). Left panel: No significant
increase of DNA-double strand breaks upon tissue culture. Right
panel: Differences between the respective mycobacterial species.
These results related with multiple factors analyzed by a factorial
ANOVA [2×6 factorial design: subject factors were cell type (1-alive and
2-apoptotic cells) and groups (1-PC, 2-MED, 3-AB, 4-AV, 5-TB, 6-NC)]
Table 1 Influence of the ex vivo culture on tissue viability
(Counting analysis of TUNEL assay)
Groups Number of cells (M ± SD) Area of cells (M ± SD) [mm2]
Alive Dead Alive Dead
Positive
control
383.75 ± 106.67 11.88 ± 10.87 64.76 ± 32.54 8.30 ± 1.05
Negative
control
284.38 ± 150.75 167 ± 84.03 49.13 ± 32.06 14.62 ± 8.664
ex vivo
sample
366.04 ± 127.50 27.43 ± 27.46 52.94 ± 31.07 1.73 ± 1.90
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cells on the peripheral (Mrank = 16.38) to be even signifi-
cantly lower than the mean rank of infected cells on the
central slides (Mrank = 34.62), U = 84.5, Z value = −4.424,
p < 0.0001 (Fig. 2b), demonstrating a sufficient infiltration
of the bacteria into the tissues.
Mycobacteria infect different cell types in the human lung
Microscopical analysis of the prepared sections with
high magnification (400×) identified different cell types
to be infected with mycobacteria (Fig. 3a and b) includ-
ing macrophages, neutrophils, monocytes, cells morpho-
logically looking like lymphocytes, and pneumocytes-II. To
characterize the frequency of the infected cell types, 30 in-
fected cells were counted from randomly chosen 30
donors’ sets of specimens (Fig. 4a and b), containing
6 mycobacterial strains, which means that all in all
30×30×6 = 5400 infected cells were counted. Experi-
ments using independent strains of the same species
lead to similar results. A total of 4.69 % [42.17 ±
14.20] of the infected cells were identified neutrophils,
3.54 % [31.83 ± 20.29] were pneumocytes-II, whereas
cells with a small cytoplasm account for 11.07 %
[99.67 ± 13.85]. Monocytes were 6.44 % [58 ± 9.91],
while macrophages were the most frequently infected
cells with 74.26 % [668.33 ± 24.65].
The percentage of infected pneumocytes-II and neu-
trophils showed significant differences depending on
the mycobacterial species used (p < 0.05, Kruskal-
Wallis test), with pneumocytes-II being more infected
with the TB-strains compared to AV and AB, and the
AB-strains being more present in neutrophils respect-
ively. Other cell types showed comparable infection
rates, such as cells morphologically appearing like
lymphocytes (p = 0.683), monocytes (p = 0.761), and mac-
rophages (p = 0.368). A correspondence analysis visualiz-
ing the susceptibility of the cell types to certain
mycobacterial strains is shown in Fig. 4c. Strains belong-
ing to the same species are plotted adjacent to each other
due to commonalities of the strains. Macrophages and
lymphocyte-looking cells are located near the plot center,
showing no special association with any strain. In other
words, infections of these two cell types were similar
among the 6 strains. By contrast, infected pneumocytes-II
were significantly more abundant after infection with TB
strains. Neutrophils and monocytes were more abundant
after AB infections.
Fig. 2 a Observation of serial sections of a whole paraffin block. Its 3D trapezoid size was approximately 0.7×0.5×0.4×0.4 mm. Serial cuts resulted
in 250 sections with a thickness of 2 μm. The 1st -50th and 201st -250th sections were considered to be identical (same marginal condition), as
well as the 51st -100th and 151st -200th sections (same para-peripheral condition). To compare incidents of infected cells among tissue, every
odd numbered slides from 1st-50th (peripheral region, N = 25) and 101st-150 (central region, N = 25) were utilized. b Distribution of infected cells
in different layers of the tissue. The x-axis shows the number of sections, the y-axis the numbers of infected cells. Descriptive statistics showed
that the peripheral slides were associated with a number of infected cells 47.87 ± 38.9, whereas, central slides had 126.92 ± 59.47 of infected cells
with high variances, followed by inferential statistics (non-parametric Mann–Whitney test)
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Morphometric considerations reveal an even higher
proportion of primarily infected cells that are not
macrophages/monocytes
The detection of a cell in these sections linearly depends
on the volume of the cell under the assumption of an
approximately round cell shape. The described cell types
have different sizes and cellular volumes (Fig. 5), which
affect the detection in the system used here (cutting,
ZN-staining). Since the volume is the third dimension of
the size (cell length), comparably small differences in the
size largely affect the detection. In order to at least
speculate about these relations in vivo, we adjusted the
detection rates according to the different cellular vol-
umes (Fig. 5, lower table).
After this correction, about 1/3 of cells infected by all
mycobacterial species were macrophages, (35.10 ± 3.59 %),
whereas neutrophils and monocytes account for 7.14 ±
2.38 and 3.05 ± 0.63 %, respectively. The percentage of
infected pneumocytes-II was 12.96 ± 7.55 % with high
variance. Interestingly, this cell type was more fre-
quently infected by TB than by any other mycobacter-
ial species analyzed (22.22 % versus 7.40 % [AV] and
9.27 % [AB]). The major group of infected cells
showed a small cytoplasm, morphologically appearing
Fig. 3 Mycobacteria are taken up by different cell types in the ex vivo infected human lung tissues a. Infected cell with labels, at × 640
magnification, intracellular bacilli were visualized by Ziel Neelsen staining in pink color, scale bar =100 μm. b. Infected cell types were shown
separetely with labels, the images were acquired at × 1000 magnification, scale bars = 30 μm
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like lymphocytes (41.75 ± 6.06 %). This was observed
regardless of the mycobacterial species used.
In order to prove the identity of infected cell types,
double-stainings of immunofluorescence and IHC were
carried out (Fig. 6). Consequently, double-stainings
allowed molecular identification of infected cell types,
including neutrophils (NE), macrophages (CD68), and
pneumocytes-II (SP-C). Due to the lack of suitable anti-
bodies, the discrimination of macrophages and mono-
cytes has not been performed. Interestingly, the
morphologically detected cells with a small cytoplasm,
which show a lymphocyte-like appearance (s. above)
remained negative with all applied antibodies (including
CD8, CD20, CD30, CD4, CD79), suggesting that these
Fig. 4 Cellular populations infected by 6 mycobacterial strains. a The frequencies of the infected cell types shown in the graph and occurrences
of absolute numbers given in the table. b 30 infected cells were counted among 2 diagonal lines in each slide and in order to involve whole tissue
equivalently as illustrated. c Correspondence analysis map for mycobacterial strains and cell types. Dispersions of all profile points produced an asymmetric
map. The centroid was labeled by a star. Around the centroid, the profile points of the various mycobacterial species (blue square) and of the different cell
types (black dot) were plotted. A bar plot of variances is shown at the left bottom part of the map
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cells are not of lymphoid origin but could have under-
gone a progressive cellular shrinkage upon infection.
Cell injuries induced by mycobacteria
Characteristic morphological changes in infected macro-
phages were recorded including cellular shrinkage and
nuclear alterations, such as karyopyknosis [which means
a shrinkage of the nuclei], karyolysis [lytic disintegration
of the nuclei], and karyorrhexis [fragmentation of the
nuclei] (Fig. 7). Among all 6 mycobacterial strains, ex-
hibition of karyolysis was 1.58 ± 2.18 %, the range of kar-
yorrhexis was 2.18 ± 2.52 %, while karyopyknosis rate
stands at 32.77 ± 4.04 % (Fig. 8a). Interestingly, karyolysis
and karyorrhexis were most common with the AV-
strains, while absent in TB. The AV-strains cause a small
part of karorrhexis, with absence of karyolysis. Among
intact infected cells, macrophages accounted for 56.25 ±
4.49 %, and monocytes for 7.23 ± 1.62 %. The differences
among strains of the same species were small.
In the case of M. abscessus infection, 31.86 % (AB1)
and 27.77 % (AB2) of infected cells showed morpho-
logical alterations. When M. tuberculosis was used (TB1
and TB2), morphological injuries in infected macro-
phages were evident in 37.44 % and in 37.19 %, respect-
ively. The percentages of morphological alterations
caused by AV1 and AV2 strains were 42.11 and 42.81 %.
These effects were remarkably higher than those ob-
served in AB and TB. Correspondence analysis reveals
association between karyopyknosis and the TB1, TB2,
and AV2 strains. Remaining intact structures of phago-
cytes were observed more often after infection with AB1
and AB2. Karyolitic and karyorrhectic cells show associ-
ation with the species M. avium (Fig. 8c).
Furthermore, results of the TUNEL assay were com-
pared respectively (Fig. 1). Here, the percentages of
apoptotic cells in control (MED) and the AB and TB-
infected specimens were 3.36 ± 3.34, 8.49 ± 7.64, and
6.15 ± 5.45 %, respectively. In comparison to the other
two mycobacterial species, AV strains induced more
apoptosis (12.24 ± 9.7 %). Likewise, the mean area per
nucleus of living cells was 162.06 units, compared to
73.41 units in dead cells, indicating nuclear shrinkage.
While estimating incidences of cellular changes, it
became obvious that some infected cells underwent
measurable shrinkage characterized by round shape
without blebbing and nuclear fragmentation (unlike
apoptosis), as well as high condensation of cytoplasm
and nucleus (unlike necrosis). In order to characterize
this atypical pyknotic change in more detail, 100 normal
and 100 infected pyknotic phagocytes were randomly
sampled from all cases and species. The above men-
tioned parameters were assessed to allow a comparison
Fig. 5 Factual proportions of infected population of cells among the 6 mycobacterial strains. The used cellular parameters for adjustments
are included
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between the groups. (Table 2, Fig. 9). The cytoplasmic
and nuclear diameters in the infected pyknotic cells were
approximately 1.69 times and 1.75 times smaller
(Mann–Whitney U test, p < 0.001), respectively, than
those of non-infected normal cells. Furthermore, their
LDs were 4.15 times darker than those of normal cells
(Mann–Whitney U test, p < 0.001). The mean rank of N/
C between infected and non-infected cells did not differ
(Mann–Whitney U test, p = 0.642), indicating that the
cellular shrinkage involved both compartments. The ob-
servation of progressive shrinkage in infected cells with
high density of cytosol supports the assumption that this
morphological change of infected cells can be a reflec-
tion of a kind of cell death induced by mycobacteria. So
far, around 15 kinds of cell deaths have been identified.
Among them, the above described cellular morphology
is in accordance with a self-split cell death, also known
as autoschizis.
Discussion
Considerations about the proposed model
Infections with pathogenic mycobacteria lead to chronic
infections in humans. Numerous in vitro and in vivo ani-
mal model systems have been developed and successfully
used to gain important insights into this very complex
host pathogen interaction. For obvious reasons the de-
tailed analysis of the molecular mechanisms happening
during the infection of the human host is very challen-
ging and often hardly possible. In this study we suggest
the recently developed STST as a powerful tool to 1) to
examine the cross-talk between human host and the in-
fectious agent, 2) to address this in an intact lung paren-
chyma with its different cell types, 3) to facilitate the
analysis of the initial pathogenesis during mycobacterial
infections and, 4) to compare different responses
induced by virulent and non-virulent strains. The ex
vivo STST model allows the investigation of all these
demands and has previously been shown to be a
source of valuable information of the early processes
stages of infections for several pathogens causing lung
diseases [34–38, 42].
Histo- and molecular-pathological analyses of the
STST samples verified successful mycobacterial infec-
tion. Serial sections of a whole block proved that infec-
tious agents diffused sufficiently deep into the tissues.
Detailed microscopic evaluation however revealed that
mycobacterial infections do not cause any histological
damages at the tissue level. By contrast, the study about
Legionella pneumophila infection by Jager J et al. used
the same ex vivo model to observe tissue damages and
epithelial delaminations [34]. The authors concluded
that this harmful extracellular adhesion of L. pneumo-
phila facilitates bacterial invasion and replication in
recruited macrophages [34].
Fig. 6 Photomicrographs of intracellular mycobacteria detected by
double staining. a Macrophages (*), b Neutrophils (□), c Pneumocytes-
II (Δ).Slides stained by combination of auramine-rhodamine (for
mycobacteria) and IHC of CD 68 (macrophages), NE (neutrophils)
and SP-C (pneumocytes-II), respectively. The fluorescence signals
of mycobacteria are red. Brightfield was used to capture
immunohistochemical detections. Images were color-inversed to
negative form which is why brown color of the color-substrate
diaminobenzidine was shifted to blue. Overlays of the fluorescent
and negative images were performed by using FixFoto. All
images were acquired at × 400 magnification, scale bar =100 μm
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As assessed by TUNEL assay, STST samples in the
current investigation had approximately 7.15 % apop-
totic cells. This is a comparably low value (in particular
with regard to the presence of mycobacteria) when com-
pared to experimental infection with other bacteria. Feng
Xu et al. studied the cellular response to S. pneumoniae
in the same model system and also performed measure-
ments of apoptosis in lung specimens by TUNEL assay.
After pneumococcal infection, a time-dependent in-
crease of apoptosis was observed and compared to the
control group (30–50 % versus 4–8 % [24 h], 40–70 %
versus 10–15 % [48 h]) [43]. Interestingly, the viability of
their control groups was in line with our samples.
Limitations of the study
Nevertheless, we need to consider that the approach
used here has its limitations. Those comprise the rela-
tively high amount of bacteria used together with the
chosen infection time of 16 h. We cannot exclude that
some of the phenotypes observed may be triggered by
the comparably high dose of cell wall components ap-
plied. Further studies are necessary to elucidate this
point for example by inclusion of heat killed bacteria or
inert materials such as beads as further controls. Such
controls are commonly used in studies of mycobacterial
infections and appropriate studies are currently under-
way to address this issue. Furthermore, the lack of kinet-
ics is a point that needs to be addressed. The different
mycobacterial species might exhibit different dynamics
within the tissue culture model. It will be a subject of fur-
ther studies to address this point together with a compre-
hensive molecular read out by e.g. transcriptomics. Indeed
it would be also desirable to study the infection with lower
bacterial doses over a longer period. Due to the declining
viability of the tissues in settings of longer than 16 h this
is currently not feasible using the STST-model, which is
why these points will be addressed by using primary cells.
Mycobacterial infections and innate immunity
According to the WHO, only 5–10 % of the individuals
latently infected with M. tuberculosis develop active tu-
berculosis disease in their lifetime [44]. Also, epidemio-
logical studies showed that only 20–50 % of people with
latent tuberculosis exhibit a positive TST skin reaction
[45–48]. These TST non-responders may suggest that
the individuals remain uninfected because of so far
uncharacterized host resistance mechanisms. In this
context the immediate clearance of the infection by the
innate immune system has been suggested, however this
issue is controversially discussed due to the lack of hu-
man studies. Hence, with the hypothesis that the innate
immune system eliminates mycobacteria, we pointed out
functional studies on the initial phase of mycobacterial
infection in human lung tissues by using the ex vivo
STST model. Firstly, all collected lung specimens of
patients were infected and showed that the initial host
defense mechanism phagocytosis seems to be actively
working. Secondly, we observed that different cell types
were infected, including macrophages, neutrophils, mono-
cytes, and pneumocytes-II. At this early stage of infection,
an involvement of all these cell types and their cooper-
ation might be the powerful capacity of innate immunity
in most individuals. Therefore, each cell type is separately
discussed below.
Fig. 7 Cellular changes in infected cells. Intracellular bacilli were visualized by Ziel Neelsen staining and appear in pink color, scale-bars = 20 μm.
a Cell schrinkage of infected macrophages (1) and normal macrophages (2), ×680 magnification. b Karyorrhexis of an infected macrophage
(×1000). c Karyolysis of an infected macrophage (×1000)
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Fig. 8 Morphologic changes in the infected phagocytes induced by mycobacteria. a Frequency of characteristic changes. The table reports
absolute numbers of incidences and sums of morphological types. b Correspondence analysis map for mycobacterial strains and cellular changes.
The map was derived from a two-cross tabulation: 1) cellular morphology types, which consisted of four elements (normal shaped
macrophages, karyorrhectic, karyopyknotic, and karyolitic phagocytes), 2) six mycobacterial strains (AB1, AB2, AV1, AV2, TB1, TB2). Dispersions of
variables produced an asymmetric map, its centroid (point of no correlation) was labeled by a star. All profile points were plotted around this
weighted average. A bar plot of variances is shown at the right top part of the map
Table 2 Cellular measurements of infected and non-infected cells (Mean ± SD)
Parameters of
measurements
Infected cells Non-infected cells
Nucleus Cytoplasm Nucleus Cytoplasm
Light density −22.83 ± 22.53 43.21 ± 22.59 23.84 ± 17.23 60.71 ± 21.40
Diameter (μm) 4.30 ± 0.77 8.40 ± 1.80 7.53 ± 1.48 14.26 ± 2.31
AM of LD 10.19 ± 18.89 42.28 ± 16.62
N/C ratio 0.52 ± 0.08 0.53 ± 0.09
Abbreviation: AM of LD arithmetic mean of nuclear and cytoplasmic LD
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Mycobacterial infections and innate immunity:
Macrophages and monocytes
A total of 900 infected cells were counted for each
mycobacterial species, whereby macrophages and mono-
cytes were predominantly infected (85.3 and 6.4 %, after
adjustment of cell volume 76.9 and 3.1 %) regardless of
the mycobacterial strains. This is in line with the major-
ity of literature reporting that mycobacteria are mainly
engulfed by macrophages and circumvent their cellu-
lar defense mechanisms to replicate within these cells
[9, 49–51]. Correspondence analysis uncovered that
monocytes had the tendency to be more likely in-
fected with AB1 and AB2 strains. Furthermore, we
observed characteristic cellular changes induced by
mycobacteria within phagocytes. These morphologic
changes comprise cell shrinkage and nuclear alter-
ations, including karyopyknosis, karyolysis, or karyor-
rhexis. Based on statistical analyses, we conclude that
M. avium strains cause significantly more cell injuries
and apoptosis. This observation is in accordance with
a previous study by Agdestein et al., who character-
ized the gene expression pattern triggered by two
strains of M. avium in human primary macrophages
[52]. As a result, they demonstrated the induction of
pro-apoptotic genes, such as RIPK2, BID, and tBID
after infection [52]. Likewise, the correlation between
apoptosis and virulence of mycobacterial strains is de-
bated [53]. Moreover, Keane et al. determined that
even in comparison among different Mtb strains, at-
tenuated variants of M. tuberculosis are associated
with macrophage apoptosis, whereas virulent strains
inhibit apoptosis to ensure their survival [54].
In the present study, monocytes were recognized by
cellular morphology only (cell size, location, shape of
nucleus) and not distinguished from macrophages via
molecular pathological methods. It had been previously
shown that monocytes phagocytizing Mtb secrete pro-
inflammatory cytokines and chemokines, such as IL-1β,
TNF-α, or IL-8 [55–58]. Since monocytes are freshly
recruited host defense cells, these events are obvious
contributions to an immune reaction. Impressive find-
ings were observed by Shaw et al. regarding the secre-
tion of IL-10 after phagocytosis of Mtb by human
monocytes without blocking autologous IL-8 secretion
[59]. The authors concluded that phagocytosis of Mtb by
human monocytes displays a specific stimulus to IL-10
secretion [59]. So it is not unlikely that successful re-
moval of mycobacterial infection may be terminated by
an early anti-inflammatory activity of monocytes to pre-
vent tissue injury, where the adaptive responses have not
been involved at that early time point.
We are convinced that tuberculocidal activity of the
innate immunity is based on the phenomenon that
humans are not uniformly susceptible to mycobacterial
infections. This may operate independently of the ac-
quired immunity via cell death induced during the initial
phase of infection. The frequent observation of progres-
sive shrinkage of infected cells with high density might
be explained by the presence of a certain kind of cell
death, namely “self-split cell death” (also known as auto-
schizis). Furthermore, autoschizis might be a potential
host defense mechanism of eliminating mycobacteria,
because its main mechanism is oxidative stress. Thus,
organelle-free cytoplasm progressively diminishes through
a series of self-excisions due to lipid peroxidation. Also the
nucleus becomes smaller; most organelles surround a small
intact nucleus in a narrow rim of cytoplasm [60–62]. Inter-
estingly, there are several lines of evidences which indicate
Fig. 9 Mycobacterial infections lead to changes in the cellular sizes and light densities. a Comparisons of nuclear and cytoplasmic sizes between
infected and non-infected cells. Mann–Whitney U-tests were performed, the ranks are given and meanings of p values labeled as asterisks
(*** = p ≤ 0.001, ns = not significant). b Comparisons of cytoplasmic (top) and nuclear (bottom) light densities (LDs) between infected and
non-infected cells. Based on the test assumptions Mann–Whitney U tests were chosen and the graphs were created by transformed data of 2
groups, as particularly infected and non-infected cells of nuclear (N = 100) and cytoplasmic (N = 100) LDs, respectively
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the killing of mycobacteria via single members of reactive
oxygen species (nitric oxide [63], peroxide [64] and reactive
nitrogen intermediates [65]).
Mycobacterial infections and innate immunity: Neutrophils
Among the six mycobacterial strains, the overall rate of
infected neutrophils was 4.7 % (after adjustment 7.1 %).
As visualized by correspondence analysis, neutrophils
were more often infected with ABs, indicating AB strains
may induce the migration of neutrophils more effect-
ively. Neutrophils are essential members of the innate
immune system, representing the most abundant type of
white blood cells (40–75 %). We observed that the aver-
age ratios of infected neutrophils were lower than those
of macrophages and monocytes. We showed that AV
strains induce the highest rates of apoptosis while the in-
cidences of infected neutrophils are significantly lower
in cases of AV strains (p = 0.007). Therefore, it seems
likely that neutrophils have been more reduced in the
AV cases due to apoptosis during incubation. Wolbers et
al. reviewed that apoptosis is a dynamic process of vari-
able length depending upon a wide variety of factors,
such as the cell type, nature of the inducing agent (i.e.,
intensity, exposure time), the involved pathway of apop-
tosis, and the measured parameters [66]. We do not
know the exact time course of apoptosis in neutrophils
induced after phagocytosis of mycobacteria in our sys-
tem. It can be quicker than overnight, but should be elu-
cidated in a further separate in vitro study. The half-life
of circulating neutrophils in the tissue under normal
conditions is, however, relatively short (6–8 h) [67] and
they are inherently pre-programed to die by inherent
apoptosis in order to minimize intracellular propagation
and parasitism of pathogens [68–70]. Therefore, it ap-
pears that the mycobacterial strategy to survive within
host cells by inhibiting apoptosis does not work in neutro-
phils. Unlike neutrophils, macrophages exhibit a longer
life span and provide an opportunity for mycobacteria to
shelter since they established strategies to circumvent
phagosomal maturation such as Mtb [71]. On the other
hand, it has been observed that mycobacteria in apoptotic
bodies were eliminated since they were not able to inhibit
the phagolysosome fusion from the inside, when they are
engulfed by fresh phagocytes [72].
Besides of apoptosis, there is some evidence show-
ing an intrinsic mycobactericidal capacity of neutrophils
via both oxidase-dependent [73–75] and independent
[76–79] mechanisms. Whether this is associated with a
distinct set of receptors used for recognition and phago-
cytosis which trigger different intracellular cascades is cur-
rently not known. In addition, epidemiological reports
suggest that neutrophils may contribute substantially to
the innate resistance of M. tuberculosis infections. Particu-
larly, the prevalence of tuberculosis among people of
African origin is known to be about as twice as high as ob-
served in Caucasian donors [80]. Lower neutrophil counts
and lower circulating concentrations of neutrophil derived
factors HNP1–3 and lipocalin 2 in these individuals when
compared to people of South Asian and Caucasian origin,
demonstrate the importance of neutrophils for the
prevention of tuberculosis [78].
Mycobacterial infections and innate immunity:
Pneumocytes-II
It has been repeatedly described that inhaled infected
droplets with mycobacteria reach the alveolar space and
are mainly engulfed by alveolar macrophages. After mor-
phometric correction, we observed 13 % of the mycobac-
terial infections in pneumocytes-II in our human ex vivo
model system. Compared to AV and AB, infected
pneumocytes-II were more common in infections with
TB strains (22.2 %), as visualized by correspondence
analysis. This finding is unexpected but demonstrates
the role of epithelial cells in the initial phase of Mtb-
infection in the human lung. According to the differ-
ences in the rates of infected pneumocytes-II by the
different mycobacterial species, we hypothesize that
NTM (AB and AV strains) induce more cell death also
to pneumocytes-II, and the cell wall features of Mtb
could exhibit a higher affinity to the receptors which
facilitate phagocytosis in pneumocytes-II compared to
those of NTM (AB and AV). On the other hand, Feng Xu
et al. studied the inflammatory response of S. pneumoniae
in a similar model system and observed that after 24 h
incubation, S. pneumoniae was predominantly detected in
alveolar macrophages compared to pneumocytes-II
[80–90 % versus 15–30 %]. Interestingly, the authors
also noticed that 48 h-stimulation increased the infection
rates of pneumocytes-II [43]. It seems to be that the in-
ternalization by pneumocytes-II is slow, since they are
considered as non-professional phagocytes. Further stud-
ies in our department are currently ongoing using primary
pneumocytes-II as an infection model.
Conclusion
In this study we demonstrate that the STST model can be
successfully employed in the analysis of mycobacterial in-
fection of human intact lung parenchyma. We observed at
the cellular level, that different cell types (macrophages,
monocytes, neutrophils, and pneumocytes-II) were in-
fected. In these infected cells, characteristic morphologic
changes (cell shrinkage and nuclear alterations) were ob-
served, most likely reflecting cell death. The infection fre-
quency of a given cell type and the infection dependent
extent of morphologic changes were significantly associ-
ated with mycobacterial species. This adds to the current
understanding of primary infection of mycobacteria.
Especially, the involvement of several cell types, their
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cooperation, cell death dependent and cell death inde-
pendent effector functions do contribute to the overall
capacity of a human individual to efficiently limit the
growth of mycobacteria upon exposure. Thus, the STST
model provides a valuable novel tool to address the com-
plex mechanisms of innate effector faction in the very
early onset of TB disease. Further studies are ongoing in
order to characterize the interaction of pathogenic myco-
bacteria with the human host at the subcellular, cellular
and supracellular organ level.
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